Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 121-128

  Zang, Na ^a,b   Li, Simin ^a   Li, Wei ^a,b   Xie, Xiaohong ^b   Ren, Luo ^a   Long, Xiaoru ^a,b   Xie, Jun ^a   Deng, Yu ^b   Fu, Zhou ^b   Xu, Fadi ^c   Liu, Enmei ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

NGF; Persistent AHR; Persistent airway inflammation; Resveratrol; RSV

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GAMMA INTERFERON; METHACHOLINE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; RESVERATROL; VIRUS RNA; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; HISTOPATHOLOGY; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; LUNG; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTOR; PNEUMONIA; RESPIRATORY FUNCTION TESTS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, VIRAL; STILBENES;

EID: 84930946765     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.05.031     Document Type: Article

References (41)

1. K.D. Boeck Respiratory syncytial virus bronchiolitis: clinical aspects and epidemiology Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro 51 1996 IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 210 213
2. R.A. Tripp, C. Oshansky, and R. Alvarez Cytokines and respiratory syncytial virus infection Proc. Am. Thorac. Soc. 2 2005 147 149
3. A.R. Falsey Respiratory syncytial virus infection in elderly and high-risk adults Exp. Lung Res. 31 Suppl 2005 (1:77)
4. R.C. Welliver Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection J. Pediatr. 143 2003 S112 S117
5. N. Sigurs, P.M. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, and F. Sigurbergsson Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13 Am. J. Respir. Crit. Care Med. 171 2005 137 141
6. J. Henderson, T.N. Hilliard, A. Sherriff, D. Stalker, N. Al Shammari, and H.M. Thomas Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study Pediatr. Allergy Immunol. 16 2005 386 392
7. G.J. Escobar, A. Ragins, S.X. Li, L. Prager, A.S. Masaquel, and P. Kipnis Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life Arch. Pediatr. Adolesc. Med. 164 2010 915 922
8. A. Mejias, S. Chavez-Bueno, A.M. Gomez, C. Somers, D. Estripeaut, and J.P. Torres Respiratory syncytial virus persistence: evidence in the mouse model Pediatr. Infect. Dis. J. 27 2008 S60 S62
9. D.A. Gentile, and D.P. Skoner Effect of respiratory syncytial virus infection during early infancy on the ontogeny of cytokine immune responses Allergy Asthma Proc. 23 2002 399 405
10. M.B. Sikkel, J.K. Quint, P. Mallia, J.A. Wedzicha, and S.L. Johnston Respiratory syncytial virus persistence in chronic obstructive pulmonary disease Pediatr. Infect. Dis. J. 27 2008 S63 S70
11. A. Tagarro, L. Perez, V.M. Quintero, and A. Canete Dexamethasone does not reduce length of hospitalization or recurrent wheezing 1 year after early bronchiolitis Minerva Pediatr. 66 2014 131 140
12. A. Beigelman, R.S. Zeiger, D. Mauger, R.C. Strunk, D.J. Jackson, and F.D. Martinez The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing J. Allergy Clin. Immunol. 133 2014 1489 1492 (92 e1-3)
13. J. Knobloch, C. Wahl, M. Feldmann, D. Jungck, J. Strauch, and E. Stoelben Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease Basic Clin. Pharmacol. Toxicol. 114 2014 202 209
14. J. Knobloch, H. Hag, D. Jungck, K. Urban, and A. Koch Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease Basic Clin. Pharmacol. Toxicol. 109 2011 138 143
15. S.G. Royce, W. Dang, G. Yuan, J. Tran, A. El Osta, and T.C. Karagiannis Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease Pathobiol. Aging Age Relat. Dis. 1 2011
16. T. Liu, N. Zang, N. Zhou, W. Li, X. Xie, and Y. Deng Resveratrol inhibits the TRIF dependent pathway by up-regulating SARM, contributing to anti-inflammatory effects after respiratory syncytial virus infection J. Virol. 88 2014 4229 4236
17. X.H. Xie, N. Zang, S.M. Li, L.J. Wang, Y. Deng, and Y. He Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells Inflammation 35 2012 1392 1401
18. N. Zang, X. Xie, Y. Deng, S. Wu, L. Wang, and C. Peng Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice J. Virol. 85 2011 13061 13068
19. L. Tortorolo, A. Langer, G. Polidori, G. Vento, B. Stampachiacchere, and L. Aloe Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection Am. J. Respir. Crit. Care Med. 172 2005 233 237
20. C. Hu, K. Wedde-Beer, A. Auais, M.M. Rodriguez, and G. Piedimonte Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs Am. J. Physiol. Lung Cell. Mol. Physiol. 283 2002 L494 L502
21. H. Ogawa, M. Azuma, H. Uehara, T. Takahashi, Y. Nishioka, and S. Sone Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA Clin. Exp. Allergy 42 2012 460 470
22. A. Kilic, S.S. Sonar, A.O. Yildirim, H. Fehrenbach, W.A. Nockher, and H. Renz Nerve growth factor induces type III collagen production in chronic allergic airway inflammation J. Allergy Clin. Immunol. 128 2011 1058 1066 (e1-4)
23. B.S. Graham, L.A. Bunton, P.F. Wright, and D.T. Karzon Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice J. Clin. Invest. 88 1991 1026 1033
24. X. Kong, G.R. Hellermann, G. Patton, M. Kumar, A. Behera, and T.S. Randall An immunocompromised BALB/c mouse model for respiratory syncytial virus infection Virol. J. 2 2005 3
25. Z.G. Chen, T.T. Zhang, H.T. Li, F.H. Chen, X.L. Zou, and J.Z. Ji Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite PLoS One 8 2013 e51268
26. S. Myou, A.R. Leff, S. Myo, E. Boetticher, J. Tong, and A.Y. Meliton Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT J. Exp. Med. 198 2003 1573 1582
27. J.B. van Woensel, R. Lutter, M.H. Biezeveld, T. Dekker, M. Nijhuis, and W.M. van Aalderen Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection Pediatr. Infect. Dis. J. 22 2003 721 726
28. N.C. Stowell, J. Seideman, H.A. Raymond, K.A. Smalley, R.J. Lamb, and D.D. Egenolf Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice Respir. Res. 10 2009 43
29. F. Aeffner, Z.P. Traylor, E.N. Yu, and I.C. Davis Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice Am. J. Physiol. Lung Cell. Mol. Physiol. 301 2011 L99 L109
30. D. Estripeaut, J.P. Torres, C.S. Somers, C. Tagliabue, S. Khokhar, and V.G. Bhoj Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model J. Infect. Dis. 198 2008 1435 1443
31. F.B. Sow, J.M. Gallup, A. Olivier, S. Krishnan, A.C. Patera, and J. Suzich Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L12 L24
32. G. Piedimonte Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection Pediatr. Infect. Dis. J. 22 2003 S66 S74 (discussion S-5)
33. V. Freund-Michel, and N. Frossard The nerve growth factor and its receptors in airway inflammatory diseases Pharmacol. Ther. 117 2008 52 76
34. T.Z. Veres, S. Rochlitzer, and A. Braun The role of neuro-immune cross-talk in the regulation of inflammation and remodelling in asthma Pharmacol. Ther. 122 2009 203 214
35. H.S. Youn, J.Y. Lee, K.A. Fitzgerald, H.A. Young, S. Akira, and D.H. Hwang Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex J. Immunol. 175 2005 3339 3346
36. T. Liu, N. Zang, N. Zhou, W. Li, X. Xie, and Y. Deng Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection J. Virol. 88 2014 4229 4236
37. M.H. Kim, D.S. Yoo, S.Y. Lee, S.E. Byeon, Y.G. Lee, and T. Min The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects Die Pharmazie 66 2011 293 300
38. S.A. Wirz, P.S. Tobias, R.J. Ulevitch, L. Aribibe, and T. Bartfai TLR2 is required for the altered transcription of p75NGF receptors in gram positive infection Neurochem. Res. 31 2006 297 301
39. Y. Jiang, G. Chen, Y. Zheng, L. Lu, C. Wu, and Y. Zhang TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-kappa B pathways Mol. Immunol. 45 2008 1557 1566
40. T. Glaab, H.G. Hoymann, M. Hecht, R. Korolewitz, T. Tschernig, and J.M. Hohlfeld Effect of anti-nerve growth factor on early and late airway responses in allergic rats Allergy 58 2003 900 904
41. B. Stampachiacchiere, L. Aloe, A. Micera, and S. Bonini Allergic bronchial airway inflammation in nerve growth factor (NGF)-deprived rats: evidence suggesting a neuroimmunomodulatory role of NGF Exp. Lung Res. 32 2006 305 320